BRENDAN WALSH - 04 Feb 2022 Form 4 Insider Report for MAXLINEAR INC (MXL)

Role: VP, Product Line Marketing
Signature: /s/ Connie Kwong, as Attorney-in-Fact
Issuer symbol: MXL
Transactions as of: 04 Feb 2022
Transactions value $: -$1,129,770
Form type: 4
Filing time: 08 Feb 2022, 16:37:27 UTC
Previous filing: 05 Jan 2022
Next filing: 23 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MXL	Common Stock	Award	$0	+3.7K	+2.7%	$0.00	141K	04 Feb 2022	Direct	F1
transaction	MXL	Common Stock	Tax liability	-$127K	-2.11K	-1.5%	$60.38	139K	07 Feb 2022	Direct	F2
transaction	MXL	Common Stock	Award	$0	+6.08K	+4.38%	$0.00	145K	07 Feb 2022	Direct	F3
transaction	MXL	Common Stock	Tax liability	-$197K	-3.27K	-2.26%	$60.38	141K	07 Feb 2022	Direct
transaction	MXL	Common Stock	Award	$0	+4.05K	+2.86%	$0.00	146K	07 Feb 2022	Direct	F3
transaction	MXL	Common Stock	Tax liability	-$131K	-2.18K	-1.5%	$60.38	143K	07 Feb 2022	Direct
transaction	MXL	Common Stock	Award	$0	+10.8K	+7.53%	$0.00	154K	07 Feb 2022	Direct	F4
transaction	MXL	Common Stock	Tax liability	-$351K	-5.81K	-3.77%	$60.38	148K	07 Feb 2022	Direct
transaction	MXL	Common Stock	Award	$0	+7.2K	+4.85%	$0.00	156K	07 Feb 2022	Direct	F4
transaction	MXL	Common Stock	Tax liability	-$234K	-3.88K	-2.49%	$60.38	152K	07 Feb 2022	Direct
transaction	MXL	Common Stock	Award	$0	+1.63K	+1.08%	$0.00	153K	07 Feb 2022	Direct	F5
transaction	MXL	Common Stock	Tax liability	-$53.1K	-880	-0.57%	$60.38	152K	07 Feb 2022	Direct
transaction	MXL	Common Stock	Award	$0	+1.09K	+0.71%	$0.00	153K	07 Feb 2022	Direct	F5
transaction	MXL	Common Stock	Tax liability	-$35.4K	-586	-0.38%	$60.38	153K	07 Feb 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Common Stock issued to the Reporting Person for the 2021 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 4, 2022.
F2	On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022.
F3	Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2019 performance-based restricted stock award granted on May 20, 2019. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022.
F4	Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022.
F5	Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 7, 2022, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 7, 2022.